Dr. Rajendra Gode College of Pharmacy Malkapur, Dist – Buldhana Maharashtra, India

*Corresponding Author: Ms. Chanchal Santosh Chandak, Assistant Professor Department of Pharmaceutics, Dr.Rajendra Gode College Of Pharmacy, Malkapur, Dist –Buldhana Maharashtra-443101, India, Phone No: 88668351200, ORCID ID: 0009-0007-2627-1596; Email: [email protected]

Received Date: July 25, 2024

Published Date: September 16, 2024

Citation: Chandak CS, et al. (2024). Gestation Concomitant: Breast Cancer. Mathews J Case Rep. 9(8):181.

Copyrights: Chandak CS, et al. (2024).

ABSTRACT

Pregnant women may be diagnosed with up to 3% of breast malignancies, according to estimates. Clinicians face unique difficulties when treating patients with breast cancer associated with pregnancy. Due to the physiological changes occurring within the breast and the investigational resources available, the diagnosis may be delayed and challenging. Additionally, if a diagnosis has been made and a staging has been performed, treatment options will be impacted by the desire to provide the mother with the best care possible while reducing risks to the foetus. This paper discusses the unique difficulties encountered in the initial diagnosis and treatment of women with pregnancy-associated breast cancer. To provide patients with the finest multidisciplinary care, considerable effort is needed when breast cancer occurs during pregnancy. Although breast cancer during pregnancy appears to be associated with distinct patterns of gene expression, the pathology-based classification remains unaffected. In the second and third trimesters of pregnancy, chemotherapy and surgery are typically safe and well-tolerated by patients. The longer time to diagnosis and the more aggressive nature of breast cancer in young people may be the main causes of the worse prognosis. The balance between the mother's and the child's health must be prioritized.

Keywords: Pregnancy, Breast Cancer, Chemotherapy, Malignancies.